The chemical constituents and biological activities of Corydalis crispa (Fumariaceae) were investigated for the first time. The phytochemical study resulted in the isolation of nine known isoquinoline alkaloids: protopine (1), 13-oxoprotopine (2), 13-oxocryptopine (3), stylopine (4), coreximine (5), rheagenine (6), ochrobirine (7), sibiricine (8) and bicuculline (9), with complete NMR data for 2 and 3 provided here for the first time. Crude extracts exhibited significant anti-inflammatory (p<0.01) activity against TNF-α production in LPS activated THP-1 cells. The acetylcholinesterase inhibitory activity of compounds 2, 4 and 7 and the antiplasmodial activity of compound 5 against P. falciparum strains TM4/8.2 and K1CB1 (multidrug resistant strain) are reported here for the first time. Stylopine (4) did not show antimalarial activity against the K1CB1 strain in contrast to a previous report. This study generated a scientific basis for the use of this plant in Bhutanese traditional medicine, either individually or in combination with other medicinal ingredients to treat a broad range of disorders. This study also identified compound 5 as potential new antimalarial lead compound.
The genus Corydalis (Fumariaceae) are a rich source of isoquinoline alkaloids which mediate chemical defence against a variety of micro-organisms and herbivores [1, 2] . While few plant species of this genus were reported for cattle and sheep poisoning [1] , many species are regarded as non-toxic and are being used in Asian folklore medicines for treating different types of ailments [3, 4] . Owing to these interesting inherent properties, the Corydalis genus has been extensively studied. More than 58 Corydalis species have been studied phytochemically with over 190 isoquinoline alkaloids reported [5] .
However, no phytochemical and biological activity studies on the Bhutanese medicinal plant, C. crispa have been reported. Locally, it is known as ngo-ba-sha-ka in Bhutan and contributes to the preparation of as many as 21 important multi-ingredient Essential Traditional Medicine Drugs (ETMDs) or polyherbal formulations [6] . As an individual plant, C. crispa is used in the Bhutanese traditional medicine (BTM) as a febrifuge and for treating infections in the blood, liver and bile which correlate to the signs and symptoms of parasitic and microbial infections, tumor and inflammatory conditions [7] . We previously reported the antiplasmodial, antimicrobial, anti-Trypanosoma brucei rhodesiense and cytotoxicity activities of the crude extracts of this plant [7] . In this study, since this plant is also ethnopharmacologically indicated for the management of various inflammatory conditions in Bhutan, we first assessed the anti-inflammatory potential of its crude extracts. We then investigated the phytochemical components of this plant followed by bioassays on the major compounds with a view to derive potential new drug lead compounds and generate scientific evidence for its ethnopharmacological uses. The phytochemical study of this plant resulted in the isolation of nine known isoquinoline alkaloids ( Figure 1 ): protopine (1), 13-oxoprotopine (2), 13-oxocryptopine (3), stylopine (4), coreximine (5) , rheagenine (6) , ochrobirine (7) , sibiricine (8) and bicuculline (9) .
Compounds 1-4 belonged to the class of protopine alkaloids; compound 5 to the class of protoberberine alkaloids; compound 6 to the class of rhoeadine alkaloids; compounds 7 and 8 to the class of spirobenzylisoquinoline alkaloids; and compound 9 to the class of phthalide-isoquinoline alkaloids. The presence of more than one class of these alkaloids from a genus or even within a species has been reported [8] . Compound 6 has been reported previously from the genus of Papaver, Meconopsis, Glaucum, Roemeria, Bocconia and Fumaria [9, 10] . However, this is the first rhoeadine-type alkaloid being isolated from the genus Corydalis (Fumariaceae). Its presence in C. crispa is not that surprising since: a) rhoeadine alkaloids have been reported from its close relative Fumaria parviflora belonging to the same family of Fumariaceae; and b) rhoeadine alkaloids are the biogenetic derivatives of protopine [10] . Furthermore, direct evidence for the incorporation of labeled protopine into rhoeadine in P. rhoeas has been documented [11] . The literature on compounds 2 and 3, lacked full NMR characterization and we have presented here for the first time ( Table 1) . (2) was previously characterized only by melting point, UV, IR and MS data [12] . Compound 2 was isolated here as a white amorphous solid. Its melting point, molecular formula and the major ion fragmentation pattern corresponded with the reported data for 13-oxoprotopine [12] [13] . The 1 H NMR spectrum of 2 showed the aromatic (CH) protons resonating at δ 7.43 (1H, s), 6.69 (1H, s), 6.83 (1H, d, J = 8 Hz), and 7.46 (1H, br s). The gHSQC showed these protons linked to the carbon signals resonating at δ 109.1 (C-1), 109.6 (C-4), 107.4 (C-11) and 125.9 (C-12), respectively.
13-Oxoprotopine
The two methylenedioxy protons were observed at δ 5.99 (2H, s) and 6.05 (2H, s) with its connected carbons resonating at δ 101.3 and 101.9, respectively. The methylene (3×CH 2 ) protons attached to C-atoms of C-5, C-6 and C-8 resonated as very broad peaks in the region of δ 1.26-3.64. The N-methyl protons resonated at δ 1.92 (3H, s). The C-13 and C-14 carbonyl groups resonated at δ 182.1 and δ 191.7, respectively. The gHMBC defined the final structure 2.
To further confirm the structure 2, it was synthesized by oxidation of compound 1 with mercuric acetate and the compound synthesized was found identical to 13-oxoprotopine (2) by TLC, MS and 1 H NMR analysis.
13-Oxocryptopine (3) was reported only from the family papaveraceae (P. somniferum) [9, 12] and this is the first report from the genus Corydalis (Fumariaceae). It was previously identified based on its melting point, MS and 1 H NMR data [12, 14] and its 13 C NMR data has been lacking. Here, this compound 3 was obtained as an optically inactive pale green solid. The molecular formula, ion fragmentation pattern and the 1 H NMR data were consistent with those reported for 13-oxocryptopine (3) [12, 14] . The APT spectra indicated the presence of three methyl groups, four methylene, four methine and ten quaternary carbons. From the gHSQC spectrum the four aromatic protons (CH) correlated to C-1, C-4, C-11 and C-12 carbons whose signals resonated at δ 111.8, 112.4, 107.4, and 125.9, respectively. A signal at δ 42.1 was assigned to the N-methyl carbon and the signals at δ 55.9 and 56.0 were assigned to the two methoxy carbons. The carbon of the methylenedioxy group resonated at δ 101.9. The long range gHMBC correlation established the structure 3.
The other known compounds were identified through MS library matching techniques (NIST08s) and then confirmed through comparison of their melting point, optical rotation, mass and NMR spectra with those reported in the relevant literature. Compound 1 (950 mg) was identified as protopine [15] [16] [17] , compound 4 (5 mg) as stylopine [15, [18] [19] [20] , compound 5 (1 mg) as coreximine [21] , compound 6 (1 mg) as rheagenine [10] , compound 7 (60.6 mg) as ochrobirine [22] [23] [24] [25] , compound 8 (0.8 mg) as sibiricine [8, 23] and compound 9 (9 mg) as bicuculline [26, 27] .
In this study, prior to the investigation of its phytochemical contents and the biological activities of the major alkaloids, we first assessed the anti-inflammatory potential of its crude extracts against proinflammatory cytokine, tumor necrosis factor-α (TNF-α) in LPS activated THP-1 cells. The uncontrolled production of this proinflammatory cytokine by the immune system in response to infection, stimulates the over production of reactive oxygen species (ROS) which have been implicated in the pathogenesis of many forms of disease [28] . Thus, the pro-inflammatory cytokine (TNFα) in LPS activated THP-1 cells are commonly used for evaluating the anti-inflammatory effects of various materials.
The anti-inflammatory assay ( Table 2 ) demonstrated the level of TNF-α secretion of THP-1 monocytic cells and the percentage of TNF-α inhibition when incubated with crude extracts and pure alkaloids of the plant in the presence of LPS. The cytotoxic effects of the crude extracts and pure alkaloids on THP-1 cells were determined first on test samples at different concentrations. This cell viability test compositely indicated that, at 50 µg/mL of crude extracts and 3.9 µg/mL of pure alkaloids, there were no significant cell reduction. The percentage of viable cells in each sample was >90%. The percentage cell viability of RPMI was 97%, DMSO was 98% and dexamethasone was 97%. This suggested that the inhibition of TNF-α production by the test samples were not associated with their cytotoxic effects to the THP-1 cells. The THP-1 cells in RPMI and THP-1 cells incubated with the crude plant extracts or pure alkaloids alone (without LPS) did not activate TNFα production at the above mentioned non-cytotoxic concentrations.
In the presence of each of the plant extracts and individual alkaloids, the TNF-α production was either suppressed or stimulated in varying degrees as compared to the secretion levels of TNF-α production of RPMI culture media control and the DMSO solvent control ( Table 2) .
Among the four different solvent extracts, the hexane and dichloromethane extract showed significant anti-inflammatory activity with the suppression of TNF-α production to the values of 142 pg/mL (77% inhibition) and 71 pg/mL (89% inhibition), respectively ( Figure 2 ). The suppression of TNF-α production of these two crude extracts were much higher than the DMSO control and the positive control drug dexamethasone ( Table 2 ). The chloroform extract also showed suppression of TNF-α production to the value of 284 pg/mL (54% inhibition). A Student's t-test with one-tailed distribution showed that the results from the hexane and dichloromethane extracts (p<0.01) and the chloroform extract (p<0.05) were statistically significant ( Figure 2 ). These significant activities suggested that these crude extracts possess compounds with promising anti-inflammatory properties.
Guided by the potent biological activities of its crude extracts, out of nine isolated compounds, we investigated six major compounds 1, 2, 4, 5, 7 and 9 for their anti-inflammatory, antiplasmodial, antimicrobial, anti-acetylcholinesterase, anti-Trypanosoma brucei rhodesiense and cytotoxicity activities ( Table 2 and Table 3 ). Compound 1 exhibited significant anti-inflammatory, anti-acetyl-cholinesterase and antiplasmodial activities against the Plasmodium falciparum strains: TM4/8.2 (a wild type chloroquine and antifolate sensitive strain) and K1CB1 (multidrug resistant strain) ( Table 2) . It also showed broad range and mild level antimicrobial activity against different bacterial strains as compared to other test compounds ( Table 3 ). The antiplasmodial, antimicrobial and antiinflammatory activities of this compound were found in line with the previously reported data [15, [29] [30] [31] [32] . Compounds 2 and 4 displayed stimulated effects on TNF-α production and moderately inhibited acetylcholinesterase. Kaya et al. [33] reported that compound 4 (stylopine) had significant antimalarial activity against the drug resistant P. falciparum K1 strain with IC 50 values of 0.23 μg/mL. However, we found that compound 4 was inactive even at the highest concentration of 4-4.6 μg/mL. Indeed, previous studies indicated that compound 4 was inactive against P. berghei and P. falciparum [15, [34] [35] . Compound 5 showed significant antiplasmodial activity against TM4/8.2 and K1CB1 strains with IC 50 values of 5.56 ± 0.63 μg/mL and 6.87 ± 1.09 μg/mL, respectively. Thus, it has the potential to be a new candidate for antimalarial drug lead. This compound also moderately inhibited acetylcholinesterase ( Table 2 ) and inhibited Helicobacter pylori and Bacillus subtilis with MIZ values of 6 and 5 mm, respectively ( Table 3 ). These MIZ values were significant when compared to that of the positive control, amoxicillin which inhibited the same strains with a MIZ values of 7 and 10 mm, respectively. However, they both showed only weak MIC values of 125 µg/mL. In fact, all the alkaloids tested here showed weak antibacterial activity against H. pylori with MIC values of 125 µg/mL. Compound 7 showed weak anti-inflammatory and moderate anti-acetylcholinesterase activities.
The anti-inflammatory, antimicrobial, antiplasmodial, anti-Trypanosoma brucei rhodesiense and the cytotoxicity activities of the crude extracts are supportive of its use in the Bhutanese traditional medicine (BTM) as a febrifuge and for treating infections in the blood, liver and bile which correlate to the signs and symptoms of parasitic and microbial infections, tumor and inflammatory conditions [7] . 578 Natural Product Communications Vol. 7 (5) 2012
Wangchuk et al. Thus, our study verified the ethnopharmacological uses of C. crispa and strongly suggested that this plant can be a source of broad spectrum, biologically active natural products. Unlike the crude chloroform extract of this plant, none of the six pure alkaloids tested here exhibited anti-Trypanosoma brucei rhodesiense and cytotoxicity activities. The anti-acetylcholinesterase activity of compounds 2, 4 and 7, and the antiplasmodial activity of compound 5 are reported here for the first time. Since compounds 1 and 5 exhibited significant antiplasmodial, moderate acetylcholinesterase inhibition and mild level antimicrobial activities, it may be deduced that these two alkaloids (in alone or synergistically) may be responsible for the major activity of this plant. It is also possible that other minor alkaloids which were isolated here (but not tested) and the non-alkaloid components which we could not readily isolate may be responsible for the broad range of interesting biological activities of the crude extract of a plant.
In summary, our study found the following: a) protopine (1) (950 mg/2 kg dry weight) was the major alkaloid of C. crispa, b) complete NMR data for compounds 2 and 3 were lacking which we furnished here for the first time, c) compound 5 showed significant in vitro antiplasmodial activity without cytotoxicity and was identified as a potential scaffold that could generate more leads with enhanced antiplasmodial activity, and d) the in vitro biological activities were in alignment with the ethnopharmacological uses of this plant and thus substantiate its use in BTM, either individually or in combination with other medicinal ingredients, to treat a broad range of disorders. Series polarimeter was used for measuring the optical rotations of the compounds using a sodium lamp and averages of ten optical readings were taken to obtain the observed rotation value.
Plant material: C. crispa Prain, is a perennial yellow flowering herb that grows to about 10-23 cm tall arising from stout woody rootstock [36] [37] . The whole part of wild C. crispa was collected from Thuphu (Altitude: 3962 Extraction and isolation: The air-dried plant material (2 kg) was chopped into small pieces and was repeatedly extracted with methanol (AR/HPLC grade, 5 × 3 L over 48 h). The extract was filtered and then concentrated using a rotary evaporator to afford the crude methanol extract (58.22 g). The MeOH extract (10 g) was acidified with 5% HCl and then subjected to sequential fractionation and extraction using hexane (5 × 60 mL) and CH 2 Cl 2 (5 × 60 mL). Two fractionated extracts were concentrated resulting into hexane extract (1.34 g) and the CH 2 Cl 2 extract (2.90 g). The remaining acidified aqueous solution was basified (pH 9-11) with NH 4 OH solution, then extracted with CHCl 3 (5  60 mL). The CHCl 3 extract was washed (H 2 O), dried (Na 2 SO 4 ) and the solvent was evaporated under reduced pressure to yield a crude alkaloidrich CHCl 3 extract (80 mg). Dragendorff's reagent was prepared [38] for staining the TLC plate loaded with alkaloid. A small portion of each of these crude extracts (40 mg each) was used for biological activity studies. Each extract obtained above was then subjected to fractional crystallization (mostly methanol/chloroform) followed by repeated separation and purification processes using column chromatography on silica gel (mobile phase: gradient eluant of increasing solvent polarities mainly using MeOH (1-30%) and CHCl 3 ) until pure alkaloids were obtained. Fractions of smaller quantities and those compounds with closer R f values were separated repeatedly using Preparative Thin Layer Chromatography. Finally, nine known isoquinoline alkaloids 1-9 (Figure 1) were isolated. ).
Anti-inflammatory assay: The methanol, hexane, dichloromethane and chloroform extracts of C. crispa were prepared using the method described by Wangchuk et al., [7] . Cell culture and in vitro bioassays were performed as previously described [39] . Cells were incubated with crude plant extracts and pure compounds of C. crispa alone or in combination with purified LPS (100 ng/mL) from Escherichia coli serotype O127 : B8 (Sigma, USA) for 3.5 hr. Supernatants were collected from individual wells by centrifugation and assayed for TNF. The cell viability or the cytotoxic effects of crude extracts and pure compounds in THP-1 cells were determined by the Trypan-blue (Gibco-Invitrogen, USA) stain exclusion assay. Cells were incubated with varying concentration of crude extracts as 0, 25, 50, 100 and 200 µg/mL and that of pure compounds as 0, 1.95, 3.9, 7.8, 15.6 and 31.25 µg/mL. The concentration that showed the highest cell viability (without significant cell reduction) was chosen as the final concentration for crude extracts (50 µg/mL) and pure compounds (3.9 µg/mL). Cell suspension was mixed with Trypan Blue which stained dead cells. The viable and dead cells were counted with a hemacytometer under an inverted microscope. Cell viability was determined from the ratio of viable cells over total cells. Results were expressed as means with standard deviations (± SD). The percentage of cell viability was calculated by the formula: % Cell viability = 100 × (1−(dead cells/total cells).
TNF-α production in THP-1 cell culture supernatants were measured using cytokine-specific sandwich quantitative enzymelinked immunosorbent assays (ELISAs) according to the manufacturer's instructions (R & D Systems, USA). The 96-well microtiter plates (Corning, USA) were coated overnight with mouse anti-human TNF-α antibody as capture antibodies. The plates were washed with PBST (0.05% Tween 20) to remove excess capture antibody. To reduce non-specific binding, wells were blocked for 2 h with bovine serum album (BSA) (1% (w/v) of BSA; Sigma, USA)) and washed with PBST. Recombinant human TNF-α was used as standard at the concentration of 15.6, 31.5, 62.5, 125, 250, 500, and 1000 pg/mL. The standard or samples were added to appropriate wells and plates were incubated overnight. After washing, biotinylated goat anti-human TNF-α antibodies were added as detection antibodies and the mixture was incubated for 2 h. The plates were washed with PBST and incubated for 20 min with streptavidin-horseradish peroxidase conjugate. The tetramethylbenzidine (TMB) substrate was added to the plates as a color indicator and was incubated for 20 min. H 2 SO 4 was added to stop the reaction. Absorbance was measured at 450 nm using a BioTek ® Synergy™ HT (Multi-Detection Microplate Reader, USA). Cytokine concentration in each well was quantified from a standard curve and expressed as pg/mL of culture medium.
The commercial anti-inflammatory drug, dexamethasone (10 µg/mL), (Atlantic LabsComp. Ltd., Thailand) was used as a positive control. The experiments were performed three times in triplicate (3×3). Results were expressed as means with standard deviations (± SD). The percentage of TNF-α inhibition was calculated by the formula: % TNF-α inhibition = 100 × ((observed/baseline) − 1).
Where observed = secreted TNF-α of experiment (pg/mL) and baseline = secreted TNF-α of DMSO (pg/mL).
Statistical significance or differences were evaluated by GraphPad Prism version 5.01 using Student's t-test with one-tailed distribution. A p-value ≤ 0.05 was considered statistically significant.
Acetylcolinesterase inhibitory assay method: A rapid TLC bioautographic method described by Marston et al. [40] was used for acetylcholinesterase inhibitory testing. Galanthamine, which is a frontline AChE inhibitor used to treat Alzheimer's disease, was used here as a reference compound. The tests were performed in triplicate.
Other bioassay methods: The antimicrobial, antiplasmodial, anti-Trypanosoma brucei rhodesiense and cytotoxicity assays were carried out using the methods, test strains and references/standard drugs as described by Wangchuk et al. [7] .
